热景生物2025年一季度业绩下滑显著，需关注应收账款及成本控制

证券之星2025-05-01

近期热景生物(688068)发布2025年一季报，证券之星财报模型分析如下：经营业绩概览热景生物(688068)在2025年第一季度的财务报告显示，公司营业总收入为9324.16万元，较去年同期下降了19.71%。归母净利润录得-2400.82万元，与2024年同期相比大幅下降574.96%。扣除非经常性损益后的净利润为-4081.68万元，同比下降20.24%。成本与费用值得注意的是，公司在本...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2532173840?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-01 09:24","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2532173840","market":"sh","top_or_hot":-1,"title":"热景生物2025年一季度业绩下滑显著，需关注应收账款及成本控制","media":"证券之星","content":"<div>\n<p>近期热景生物(688068)发布2025年一季报，证券之星财报模型分析如下：经营业绩概览热景生物(688068)在2025年第一季度的财务报告显示，公司营业总收入为9324.16万元，较去年同期下降了19.71%。归母净利润录得-2400.82万元，与2024年同期相比大幅下降574.96%。扣除非经常性损益后的净利润为-4081.68万元，同比下降20.24%。成本与费用值得注意的是，公司在本...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501092558a6cf8585&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>热景生物2025年一季度业绩下滑显著，需关注应收账款及成本控制</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n热景生物2025年一季度业绩下滑显著，需关注应收账款及成本控制\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-01 09:24 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501092558a6cf8585&s=b><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近期热景生物(688068)发布2025年一季报，证券之星财报模型分析如下：经营业绩概览热景生物(688068)在2025年第一季度的财务报告显示，公司营业总收入为9324.16万元，较去年同期下降了19.71%。归母净利润录得-2400.82万元，与2024年同期相比大幅下降574.96%。扣除非经常性损益后的净利润为-4081.68万元，同比下降20.24%。成本与费用值得注意的是，公司在本...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501092558a6cf8585&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501092558a6cf8585&s=b","article_id":"2532173840","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501092558a6cf8585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2532173840","pubTimestamp":1746062641,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近期热景生物发布2025年一季报，证券之星财报模型分析如下：经营业绩概览热景生物在2025年第一季度的财务报告显示，公司营业总收入为9324.16万元，较去年同期下降了19.71%。归母净利润录得-2400.82万元，与2024年同期相比大幅下降574.96%。应收账款增长至1.14亿元，同比增加了177.97%，这一变化值得特别关注，因为较高的应收账款可能影响公司的现金流健康。总结综合以上分析，热景生物在2025年第一季度的表现较为疲软，尤其是在盈利能力和成本控制方面存在挑战。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688068":"热景生物","BK0239":"医药制造"},"translate_title":"Rejing Biotech's performance in the first quarter of 2025 has declined significantly, so we need to pay attention to accounts receivable and cost control","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688068":1},"content_text":"近期热景生物(688068)发布2025年一季报，证券之星财报模型分析如下：经营业绩概览热景生物(688068)在2025年第一季度的财务报告显示，公司营业总收入为9324.16万元，较去年同期下降了19.71%。归母净利润录得-2400.82万元，与2024年同期相比大幅下降574.96%。扣除非经常性损益后的净利润为-4081.68万元，同比下降20.24%。成本与费用值得注意的是，公司在本报告期内的三费(销售费用、管理费用、财务费用)占比显著上升，总和达到6016.76万元，占总营收的比例从去年同期的45.45%增至64.53%，增幅达41.98%。这表明公司在成本控制方面面临较大压力。盈利能力从盈利能力来看，公司的毛利率为47.27%，同比减少了19.94个百分点；净利率则降至-26.35%，同比大幅下降966.55%。每股收益为-0.26元，同比减少533.33%。这些数据显示出公司在盈利能力上的明显减弱。资产状况此外，公司的货币资金余额为1.79亿元，较上一年度减少了23.64%。应收账款增长至1.14亿元，同比增加了177.97%，这一变化值得特别关注，因为较高的应收账款可能影响公司的现金流健康。有息负债也从191.63万元激增至5011.35万元，增幅高达2515.09%。现金流情况每股经营性现金流为-0.11元，虽然同比改善了29.78%，但仍处于负值状态，反映出公司在经营活动中的现金流出仍然超过流入。总结综合以上分析，热景生物在2025年第一季度的表现较为疲软，尤其是在盈利能力和成本控制方面存在挑战。同时，快速增长的应收账款和大幅增加的有息负债也为公司未来的财务稳定性带来了不确定性。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2532173840","isCrawlerRequest":true}